Mozobil Boosts Stem Cells Before Bone Marrow Transplants
12/19/2008
HealthDay - FRIDAY, Dec. 19 (HealthDay News) -- The Genzyme Corp. drug
Mozobil (plerixafor) has been approved by the U.S. Food and Drug
Administration to boost a person's blood stem cell count before a bone
marrow transplant, the agency said in a news release.
More: - From the site
Share and enjoy
Post Comment
Entry 1 of 16100
Last Page | Next Page